已发表论文

特应性皮炎与肠道微生物群相关性研究进展

 

Authors Mao Q, Wang X, Cai H, Yang J, Zhang Y, Min W, Qian Q, Zeng Y

Received 29 September 2023

Accepted for publication 2 June 2024

Published 8 July 2024 Volume 2024:17 Pages 1613—1619

DOI https://doi.org/10.2147/CCID.S442551

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Jeffrey Weinberg

Qiuyu Mao,1 Xinyi Wang,1 Haibin Cai,1 Jingyi Yang,2 Yiwen Zhang,2 Wei Min,2 Qihong Qian,2 Yibin Zeng1 

1Department of Dermatology, Minhang Hospital, Fudan University, Shanghai, People’s Republic of China; 2Department of Dermatology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, People’s Republic of China

Correspondence: Qihong Qian; Yibin Zeng, Email qqihong@126.com; mitangbaba@163.com

Abstract: Atopic dermatitis (AD) is a common skin disease, the pathogenesis of which has not been fully elucidated. The gut microbiota is the largest micro-ecosystem in the human body that affects the immune system and skin barrier function. Recent studies have shown that in addition to the environmental factors, skin barrier, genetic factors and immune response, gut microbiota disturbance may also cause AD. This review described the correlation of AD with gut microbiota and existing research status of AD treatment via targeting gut microbiota.

Keywords: atopic dermatitis, gut microbiota, fecal microbiota transplantation